Examining how muscle loss affects disease progression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the impact of sarcopenia, a condition characterized by muscle loss, on the prognosis of patients with liver cirrhosis, cancer, and those requiring mechanical ventilation. The study will utilize ultrasound-based measurements and serological muscle markers to assess muscle quantity and quality, providing a simpler alternative to more complex diagnostic methods. By identifying the relationship between sarcopenia and disease outcomes, the research seeks to enhance early prognostic estimations for affected patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* oncological patient in the field of gastrointestinal tumors
* patients with liver cirrhosis
* patients attending the intensive care unit

Exclusion Criteria:

* patients incapable of consenting
* patients with congenital muscle diseases

Where it's running

• Universitatsmedizin Mainz
  Mainz, Rhineland-Palatinate, Germany Recruiting

Study contacts

• Study coordinator: Wolfgang Maximilian Kremer Kremer, MD
• Email: maximilian.kremer@unimedizin-mainz.de
• Phone: 00496131175711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Spatial multi-omics and AI-based early warning for pancreatic cancer cachexia

  This study tests whether spatial multi-omics data can reveal how the tumor and body metabolism interact in pancreatic cancer cachexia and whether a multimodal AI model can predict cachexia early in adults with pancreatic ductal adenocarcinoma.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT07670286

• Even protein distribution plus exercise for people awaiting liver transplant

  This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.

  Recruiting at 2 sites Agricultural University of Athens · Athens, Attica and 1 other locations · NCT07561138

• Pathogenesis and Reversal Strategies for Cancer Cachexia Using Multi-Omics

  This study uses multiple omics methods and nutritional interventions to try to find causes and reversal strategies for cachexia in adults with gastrointestinal cancers.

  Recruiting China Medical University, China · Shenyang, Liaoning · NCT07519837

• Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions

  This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.

  Recruiting University of Missouri-Columbia · Columbia, Missouri · NCT07083557

• High-protein, plant-dominant diet for people with liver cirrhosis

  This 6-month test compares a high-protein, mostly plant-based diet to a usual low-fat animal-protein diet in adults with decompensated cirrhosis who are awaiting kidney transplant to see which better preserves nutrition and muscle.

  Recruiting at 2 sites Agricultural University of Athens · Athens, Attica and 1 other locations · NCT07028580

• Assessing muscle loss and liver health in patients with advanced liver disease

  This study is testing how muscle loss affects liver health in people with advanced liver disease by looking at their body composition and overall well-being over two years.

  Recruiting at 3 sites Linkoeping University · Eksjö and 2 other locations · NCT05502198

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.